113 related articles for article (PubMed ID: 3003310)
1. Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas.
Monaghan P; Roberts JD
J Pathol; 1985 Dec; 147(4):281-9. PubMed ID: 3003310
[TBL] [Abstract][Full Text] [Related]
2. Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations.
Nesland JM; Holm R; Johannessen JV; Gould VE
J Pathol; 1986 Jan; 148(1):35-43. PubMed ID: 3003312
[TBL] [Abstract][Full Text] [Related]
3. A study of different markers for neuroendocrine differentiation in breast carcinomas.
Nesland JM; Holm R; Johannessen JV
Pathol Res Pract; 1986 Oct; 181(5):524-30. PubMed ID: 2431399
[TBL] [Abstract][Full Text] [Related]
4. Electron microscopy and immunostaining of the normal breast and its benign lesions. A search for neuroendocrine cells.
Nesland JM; Lunde S; Holm R; Johannessen JV
Histol Histopathol; 1987 Jan; 2(1):73-7. PubMed ID: 2980706
[TBL] [Abstract][Full Text] [Related]
5. Distribution of dense core granules in normal, benign and malignant breast tissue.
Ferguson DJ; Anderson TJ
J Pathol; 1985 Sep; 147(1):59-65. PubMed ID: 2995627
[TBL] [Abstract][Full Text] [Related]
6. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase.
Seshi B; True L; Carter D; Rosai J
Am J Pathol; 1988 May; 131(2):258-69. PubMed ID: 3282444
[TBL] [Abstract][Full Text] [Related]
8. Nuclear DNA content in breast carcinomas with neuroendocrine differentiation.
Nesland JM; Pettersen EO; Fosså SD; Høie J; Johannessen JV
J Pathol; 1986 Nov; 150(3):181-5. PubMed ID: 3027292
[TBL] [Abstract][Full Text] [Related]
9. Fine needle aspiration cytology of a male breast carcinoma exhibiting neuroendocrine differentiation. Report of a case with immunohistochemical, flow cytometric and ultrastructural analysis.
Feczko JD; Rosales RN; Cramer HM; Goulet RJ; Tao LC
Acta Cytol; 1995; 39(4):803-8. PubMed ID: 7631560
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine differentiation in colorectal carcinomas.
Syversen U; Halvorsen T; Mårvik R; Waldum HL
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
[TBL] [Abstract][Full Text] [Related]
11. Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study.
Lunde S; Nesland JM; Holm R; Johannessen JV
Pathol Res Pract; 1987 Oct; 182(5):627-31. PubMed ID: 2825146
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.
Papotti M; Macrì L; Finzi G; Capella C; Eusebi V; Bussolati G
Semin Diagn Pathol; 1989 May; 6(2):174-88. PubMed ID: 2503862
[TBL] [Abstract][Full Text] [Related]
13. Breast carcinomas with neuroendocrine differentiation.
Nesland JM; Memoli VA; Holm R; Gould VE; Johannessen JV
Ultrastruct Pathol; 1985; 8(2-3):225-40. PubMed ID: 4060259
[TBL] [Abstract][Full Text] [Related]
14. [Organ-specific ultrastructural cellular signs of cancerous breast tumors].
Topuriia IV
Arkh Patol; 1981; 43(11):57-63. PubMed ID: 6274281
[TBL] [Abstract][Full Text] [Related]
15. Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC 11.
Angus B; Napier J; Purvis J; Ellis IO; Hawkins RA; Carpenter F; Horne CH
J Pathol; 1986 Aug; 149(4):301-6. PubMed ID: 3020217
[TBL] [Abstract][Full Text] [Related]
16. Neuron-specific enolase expression and neuroendocrine differentiation in carcinomas of the breast.
Wilander E; Påhlman S; Sällström J; Lindgren A
Arch Pathol Lab Med; 1987 Sep; 111(9):830-2. PubMed ID: 3632300
[TBL] [Abstract][Full Text] [Related]
17. Transferrin receptor expression in non-malignant and malignant human breast tissue.
Walker RA; Day SJ
J Pathol; 1986 Mar; 148(3):217-24. PubMed ID: 3009766
[TBL] [Abstract][Full Text] [Related]
18. An ultrastructural evaluation of cell heterogeneity in invasive ductal carcinomas of the human breast. I. An in vivo study.
Pucci-Minafra I; Minafra S; Faccini AM; Alessandro R
J Submicrosc Cytol Pathol; 1989 Jul; 21(3):475-88. PubMed ID: 2551481
[TBL] [Abstract][Full Text] [Related]
19. [Ultrastructural characteristics of the parenchymatous cells in breast cancer].
Lomaia TG
Biull Eksp Biol Med; 1982 Jul; 94(7):77-80. PubMed ID: 6289932
[TBL] [Abstract][Full Text] [Related]
20. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
Jones JL; Glynn P; Walker RA
J Pathol; 1999 Oct; 189(2):161-8. PubMed ID: 10547569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
